SLN

#2241
Silence Therapeutics Plc American Depository Share
5.44
+1.30%
Sector:
Base:
Profit Currency:
Daily Range
5.44
5.44
Year Range
1.97
7.78
Daily Change
+1.30%
Monthly Change
+5.84%
6 month change
+4.02%
Year Change
+15.74%
Previous Close
5.37
Open
5.44
Bid
Ask
Low
5.44
High
5.44
Volume
6
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

News